<DOC>
	<DOCNO>NCT01338103</DOCNO>
	<brief_summary>The purpose study determine whether Rituximab , dose use rheumatoid arthritis patient , benefit pemphigus patient . It also test immune function via Cylex assay pemphigus patient treatment RItuximab .</brief_summary>
	<brief_title>Treatment Pemphigus Patients With Rituximab 1000mgX2 Assessment Immune Status Via Cylex</brief_title>
	<detailed_description />
	<mesh_term>Pemphigus</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>1 . Pemphigus patient moderatesevere disease 1 . Pregnancy lactation 2 . Woman reproductive age use birth control measure . 3 . Prior severe allergy anaphylaxis human monoclonal antibody 4 . Heart failure 5 . Unstable angina ischemic heart disease 6 . Uncontrolled arrhythmia 7 . HIV positive 8 . Active hepatitis B infection positive hepatitis C virus ( HCV ) antibody . 9 . Severe dementia psychiatric illness 10 . Active acute infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Pemphigus</keyword>
	<keyword>Rituximab</keyword>
	<keyword>Cylex</keyword>
</DOC>